StreetAlpha.app
Home › Stocks › SEER

Seer, Inc. (SEER)

Healthcare
$1.46
▼ −1.35%
LAST CLOSE · NOV 17

Seer makes the Proteograph Product Suite, a set of tools for deep, unbiased protein measurement used by life science researchers. It last closed at $1.46 on Nov 17, down 1.35% on the day. SEER last reported earnings on Tue, Aug 11, 2026.

AI Auto Pilots
Is SEER in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$14.1M
−14.0% vs a year ago
Net income
−$63.5M
−450.9% margin
Free cash flow
−$46.4M
−329.3% margin
Gross margin
46.5%
$6.5M gross profit
Valuation
Market cap
$81.5M
55.8M shares
P/E
–
Price to sales
5.8
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$29.3M
At Sep 30
Shareholder equity
$212.9M
Shares outstanding
55.8M
At Nov 6
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $6.6M$6.6MFY2021FY2022: $15.5M$15.5MFY2022FY2023: $16.7M$16.7MFY2023FY2024: $14.2M$14.2MFY2024FY2025: $16.6M$16.6MFY2025

From SEER's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Last report
Aug 11
2026 · After the close (AMC)
Reported EPS
-$0.31
vs -$0.27 est. · miss
Year-ago EPS
—
Not on file
Options-implied move
±25.1%
Priced in before that report
Analyst consensus
—
No ratings in 90 days
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
No firm has rated SEER in the past 90 days.
Average 12-month target
No price targets on SEER in the past 90 days.
Latest rating changes
Canaccord GenuityInitiated
May 4Buy$4
DateFirmActionRatingPrice target
May 4Canaccord GenuityInitiatedBuy$4
Loading…

Technical Analysis

SEER · as of the Nov 17 close · updated after every close
Downtrend, oversold

The stock is 19% below its 20 day and 31% below its 50 day average. It is 30% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 22), oversold. The nearest support is the Pivot at $1.45, and the nearest resistance the Pivot R1 at $1.49.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 6.4%/day
Key levels
$2.3852 week high+63.0%
$1.98100 day average+35.6%
$1.9250 day average+31.5%
$1.90200 day average+30.1%
$1.77Swing high (Jun 15)+21.2%
$1.7420 day average+19.2%
$1.49Pivot R1+2.1%
$1.46Last close
$1.45Pivot−0.7%
$1.43Pivot S1−2.1%
$1.4252 week low−2.7%
Indicators
RSI (14)21.96Oversold below 30Oversold
MACD-0.13Below its signal lineBearish
Stochastic5.5Near the bottom of its rangeOversold
ADX (14)34.5Trending down
Williams %R-93.9Oversold below −80, overbought above −20Oversold
CCI (20)-127.6Oversold below −100, overbought above 100Oversold
Rate of change−15.6%Change over 10 sessionsBearish
ATR (14)$0.09Typical daily range, 6.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for SEER

What happened before

See how SEER did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow SEER usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How SEER has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in SEER in the last 90 days.

Loading…

See today’s whale options flow across the market →

SEER Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲34 buying vs 20 selling
  • ▲Held by funds +1.6 pts
  • ▲Funds holding +9
  • ▲Superinvestors: 2 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding6859+15.3%
In funds' top 1021+100.0%
Held by funds38.5%36.9%+1.6 pts
New / increased15 / 199 / 15+41.7%
Reduced / sold out14 / 619 / 8−25.9%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SEER institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SEER is in one of them and how their past SEER trades turned out.

SEER in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SEER in an article yet. Here's the latest on the wider market.

About Seer

Seer is a life sciences company based in Redwood City, California, that makes tools for studying proteins. Its main offering, the Proteograph Product Suite, combines consumable assays, an automation instrument and data analysis software to measure proteins in samples such as blood plasma. Researchers use it to examine protein variants and modifications at the peptide level, which can add context to genetic data. Its customers include academic institutions, biopharmaceutical companies, biobanks and clinical research organizations.

Headquarters
Redwood City, CA